The documents claim that protection from Pfizer's vaccine loses some effectiveness after six months but improves to 95% after a third dose.
In a separate document, FDA staff noted they have yet to verify some data that would support an additional dose, saying the current vaccines "still afford protection against severe COVID-19 disease and death in the United States.".